Same-Day Discharge After Transcatheter Aortic Valve Implantation: Who, When, and How?

Area of Science:

• Cardiology
• Interventional Cardiology
• Health Services Research

Background:

• The prevalence of severe aortic stenosis is increasing due to aging populations, leading to higher healthcare demands.
• Transcatheter aortic valve implantation (TAVI) procedures are rising, necessitating efficient healthcare delivery models.
• Previous studies on same-day discharge (SDD) after coronary angioplasty suggest its safety, particularly in transfemoral cases.

Purpose of the Study:

• To provide an overview of the safety and efficacy of same-day discharge (SDD) after transcatheter aortic valve implantation (TAVI).
• To offer guidance on implementing SDD-TAVI services to enhance healthcare efficiency and patient outcomes.
• To highlight the need for randomized trials to validate SDD-TAVI practices.

Main Methods:

• Review of existing observational studies on SDD after TAVI.
• Analysis of technological advancements and procedural evolution in TAVI.
• Discussion of patient selection criteria and minimalist TAVI approaches for SDD.

Main Results:

• Observational studies indicate that SDD after TAVI is safe and effective.
• Careful patient selection and a minimalist TAVI approach are key to successful SDD.
• SDD-TAVI has the potential to improve healthcare system efficiency and patient satisfaction.

Conclusions:

• SDD-TAVI is a viable strategy for selected low-risk patients.
• Successful implementation requires careful patient selection, procedural optimization, and robust follow-up.
• Further randomized trials are needed to confirm the benefits of SDD-TAVI.